Jim Cramer: Buy Groupon and Coca-Cola, and 3 More Stock Picks

Jim Cramer made the following calls on October 23rd, 2013. What do you think about his picks?

Groupon Inc (NASDAQ:GRPN): Jim Cramer ranked this stock a Buy. Cramer previously ranked this stock a Buy on July 2, 2013. The stock’s 52-week high is $12.17, and its 52-week low is $2.60. Cramer acknowledged that Groupon was a speculative pick, but he said that the company has a good CEO as well as a ton of potential for the future. With the share price not as expensive as touted companies such as Tesla or Netflix, Cramer said that now just might be the time to jump on board with the online deal provider.

grpn-20131024

The Coca-Cola Company (NYSE:KO): Jim Cramer ranked this stock a Buy. Cramer previously ranked this stock a Buy on October 9, 2013. The stock’s 52-week high is $43.43, and its 52-week low is $35.58. Cramer gave his blessing to Coca-Cola for the second time this month. This time, Cramer said that, with commodity prices falling fuether, one can expect companies that are dependent on commodities as inputs — such as Coca-Cola — to perform well.

ko-201313024

The Hain Celestial Group, Inc. (NASDAQ:HAIN): Jim Cramer ranked this stock a Buy. Cramer previously ranked this stock a Buy on June 10, 2013. The stock’s 52-week high is $85.48, and its 52-week low is $51.51. Cramer was a fan of the conglomerate of various brand names in the food industry, specializing in organic and natural products. As commodity prices drop, companies such as Hain Celestial are well suited to utilize the cost savings that this leads to, driving the company’s efficiency — as well as its stock price — ever higher.

hain-20131024

Johnson & Johnson (NYSE:JNJ): Jim Cramer ranked this stock a Buy. Cramer previously ranked this stock a Buy on October 22, 2013. The stock’s 52-week high is $94.42, and its 52-week low is $66.97. Cramer reiterated his buy ranking on Johnson & Johnson, effectively praising the new leadership in the company as being key to its turnaround. He said that investing in the company is a way to get one’s foot into the consumer products, medical device, and pharmaceutical sectors all at once, noting that Johnson & Johnson comes with solid fundamentals and cash on its balance sheet included free of charge.

jnj-20131024

Molycorp, Inc (NYSE:MCP): Jim Cramer ranked this stock a Sell. Cramer previously ranked this stock a Sell on March 12, 2013. The stock’s 52-week high is $14.44, and its 52-week low is $4.70. Cramer was pessimistic about Molycorp, not wanting to dabble in the field of rare earth elements. He also said that he found weaknesses in the company’s balance sheet, which makes him feel safer investing his money elsewhere.

mcp-20131024

Don’t Miss: Latest Mercedes C-Class Brings Design to a Whole New Level.

More from The Cheat Sheet